NCT07182045 Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.
| NCT ID | NCT07182045 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Myoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-09-18 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-09-18 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.
Eligibility Criteria
Inclusion Criteria: * Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/\>5cm or * Patients undergoing minimally invasive Myomectomy with =/\> 5 fibroids Exclusion Criteria: * Pregnancy, * Age \<18yo, * Patients undergoing concomitant surgery such as endometriosis surgery, * Suspected malignancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07182045 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Myoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07182045 currently recruiting?
Yes, NCT07182045 is actively recruiting participants. Contact the research team at randa.j.jalloul@uth.tmc.edu for enrollment information.
Where is the NCT07182045 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07182045 clinical trial?
NCT07182045 is sponsored by The University of Texas Health Science Center, Houston. The trial plans to enroll 120 participants.